Face the facts: there is no news, there are no revs, this fish is flopping

Many of the folks who drove that run are gone—some LONG gone

Congratulations—awesome to see big $ being made and fast! NNS* has been killing it lately too. Should have KNOWN 3+ months ago that WE were driving this up, and that THEY didn’t want it up: I was all over the idea (not much else logical to explain actions and inactions), but I just could never fathom that deeply engaged and invested PRINCIPALS would EVER want their shares to do ANYTHING but go up. Good to know...

-10% here, -10% there—but who’s counting? “How low can ya go”:

They might wanna 8-K something substantial FAST

Peace and prayers for your family, doc

This week was the first official PR-sourced mention of the website, no? I said long ago that they had a choice: get in front of stories, or be driven to them. That, mercifully, is life in the Information Age. Thankfully folks here have intelligence, persistence, and time—and you lead the way, JB!

You are extremely diligent—and we thank you!

Out of curiosity, what % of the items you list AFTER the last 10-Q are sourced in direct company communications (as opposed to your dogged fact-finding)? Tea leaves, divining rods, and crystal balls are SO truly medieval...

Many of us weren’t here in those days—and the fact remains that the business model will easily support PPS in the 5-10¢ range now: the fact that it’s not there is conscious and willful, in my opinion. There is ALWAYS a reason for what we see—in some cases it just takes some time to synthesize the sundry strands of information delivered so deliberately and diffusely.

NOW it’s making a bit more sense: run to .07 was driven by energy, DD, and buying HERE—and was not really catalyzed or supported by explicit news and activities by management, as has widely been recognized here. Soooo, who would want to see a return of the PPS to a “more manageable level” and why? Could it be these very “institutional investors” we’re hearing about now, whose terms may have been too uncomfortable for them at those higher PPS levels, and may instead have been predicated on these lower valuations? Time will tell—and we WILL understand at a very granular level WTF has been going on over the last several months: TRUST AND BELIEVE.

Au contraire, mon frere: I have my sights set on the milly club with CELZ shares (I’d be there already, but the stagnation of the last 3 months suggested the need to diversify: I want to make money now AND later).

As for “the market” not being to blame: I suppose the precipitous plummet from .07 to the mid-.02s was due to an overwhelming number of buyers? As for bipolar, if stating bad and good views about the same entity within the same lifetime—and erring on the side of the negative in the event of a tie, at least until disproven explicitly—makes me bipolar, then so be it.

Market is tired of inference and innuendo, stealth and subterfuge. Add to that the apparent reality that most longs are, for the most part, bought in about as much as they can afford right now—and that explains most of what you need to know. Finally, not helping matters is the fact that I would be FLOORED AND FLABBERGASTED if, out of 100 people on the street, TWO could tell you anything relevant about CaverStem unprompted: I would barbecue my shoes and take a nice big bite if proven wrong legitimately.

What’s a conservative estimate of the value of their current capital holdings?

I’m sorry, but this company looks like it’s about to go belly up: convince me otherwise with FACTS...

When? How many of ALL their facilities/properties are generating REVS, how much, and over what period of time? I’m new here, but all I can see are loans, grants, and acquisitions: “where’s the beef?”

Here’s what that might look like—with VERY conservative estimates for ALL these. Assume there are, at a point in the not too distant future:

100 total physicians performing
2 CaverStem procedures a day
60 biz days during the avg quarter
4 quarters per year
X $1200 NET to CELZ per procedure
—————————————————-
$57,600,000
VERY conservatively for CaverStem ALONE

Now, we ALL know that, given the worldwide scope of this even at this early stage, the first number (total physicians performing is likely to be greater than 100), and the average of 2 procedures per doctor (which may be low NOW!) is more likely to be in the neighborhood of 5+, given the brief amount of time CaverStem takes from start to finish...

I believe this to be true.

Given their approach to date, do you REALLY expect them to release meat and potatoes? I predict that today’s release is as juicy as it gets for this round: why would they release today’s if they intended to provide something major just a few days later. They’ll disappear again for 3 weeks—that’s their new pattern...

It’s one thing for institutions to engage with CELZ primarily as a funding mechanism (i.e. loans)—QUITE another to have “institutional holders” as that is traditionally used and understood.

How: where’s the BEEF (revs)?

Need to see evidence of substantial increase in revs Q/Q, Y/Y, along with some informative PRs that paint the same strong financial picture going forward: at that point I’ll believe we can hit .10-.25

It rose as high as $2.50/share, but the deal was closed for something in the $1.60s. Different company, some similar officers—technically nothing at all to do with CELZ. Moreover, Medistem was nowhere near commercialization, CELZ is the NOW—and we’re STILL sucking canal water!

The only people, for the most part, who aren’t howling to the hills right now are the ones who were fortunate enough to get in below 1¢. For anyone else this is NOT north

I’ve added all intend to until this takes a northward turn above .05 FOR GOOD

They have THIS patent on THEIR procedure—but there is nothing to prevent bigger fish from making their own, and leaving us in their wake...

I’m not saying they haven’t thought of this and much more—but thinking ain’t DOING...and this danger is very real

Still broken—can you copy and paste into here (or at least summarize the essence of what you see analytically)?

I have believed everything contained in this message since buying in back in February. However, their IMPLEMENTATION/EXECUTION of their commercialization of the business plan is sluggish and laggard at best.

It is also no secret that they are not the only one working on these issues in this space—in fact, much of CELZ’ scientific work cites OTHER doctors and studies (and these are fairly easy to find).

Here’s what I sense: bigger firms (perhaps big pharma) are going to find and/or market similar procedures BEFORE CaverStem becomes a widely known, “industry-disrupting” brand name. This danger is REAL, and we would no longer be in the catbird seat at that point.

The alternative is to get more aggressive with marketing and promotion ASAP. Even if you create a demand that you currently do not have the capacity to satisfy, you are getting your brand HUGE name recognition as THE LEADER in this arena. Provided that you shave an equally systematic and aggressive process for recruiting/signing/training doctors, you will burn through that backlog in short order (given that the procedure takes about 30 minutes from start to finish)—but you WILL NOT be “overtaken” in the race by bigger fish in the meantime...

Well said

Looks like the CTO in question is in effect until 2025 (wow—that’s a LONG time to allow a company to fly under the radar without fully disclosing to shareholders elements normally required, absent the CTO):

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=138947132

“Page not found.” What did you imagine the graphic meant/what story do you see taking shape with that stock (and his does that relate to CELZ)?

Correct:

https://www.google.com/amp/s/www.bizjournals.com/charlotte/news/2017/09/29/blue-sphere-signs-66m-green-gas-contract.amp.html

I’m incorrect about the market cap, but the rest is accurate—and that stock was just recently at $2.50 PPS (and higher before that)

We’ve been hoping that for 4+months. Getting any information is like pulling teeth. Especially frustrating when I see stocks with lower floats and higher market caps where CEOs reply directly (and not infrequently) to shareholders who contact them by email (just check the “trash” stock where you will quickly see a link to a tweet that contains an image of a letter). Some companies “get it” and understand how to manage shareholder relations in the 21st century...

Why are we taking this issue with the apparent gagging of the TA lying down?? NSX, Yooper, and I have posted a little about it recently, but it doesn’t seem to be registering within the wider consciousness on this board.

Least dynamic management EVER.

+1 (sadly)

In the end, folks are being expected to take a lot on faith, “trust,” “remember Medistem.”etc—stuff that, technically speaking is not verifiable, doesn’t “prove” anything, and/or has little to nothing to do specifically with CELZ. However, until further notice, OTC is OTC—and they seem in no hurry (or shape, quite honestly) to get out and up...

They are not interested in shareholder input on nearly any aspect: they “got this.”

Thanks for the info! So what does DTC do, and how is the handling of these shares specifically and practically relevant?

Based on my reading of the article I posted, VStock is ALREADY participating in the “Transfer Agent Verified Share Program,” and is therefore not waiting until 1/1/2019 (like the 5 NEW participants are). I’m not asserting wrongdoing either: I’m simply providing another basis to dispute their claim that “the TA is just doing its job” by not responding to shareholder requests about the current-to-the-day share structure.